Capa, Sheila Mae .
HRN: 00-72-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/17/2025
05/23/2025
IV
500mg
Q8
SP PLTCS WITH IUD INSERTION
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes